EC proposes IVDR extension to ensure diagnostics availability
The revision includes measures to enhance transparency in the medical device sector. Credit: vipra gen from Pixabay. The European Commission (EC) has proposed an extension of the transition period for the IVDR, aiming to maintain the availability of essential healthcare products and ensure patient care. The revision also includes measures to enhance transparency in the […]
Somerset NHS uses Allurion’s gastric balloon to treat first patients
Allurion’s weight loss balloon eliminates the need for surgery, endoscopy or anaesthesia. Credit: Allurion. Somerset NHS Foundation Trust in the UK has treated the first patients with the Allurion gastric balloon for pre-surgical weight loss. The non-surgical, swallowable balloon aids in pre-surgical weight loss and remains in the stomach for around four months, facilitating an […]
CN Bio and Altis team up for integrated ‘organ-on-chip’ model
The systems are expected to eliminate the need for pre-clinical animal tests and cut down on drug development costs. Credit: Mongkolchon Akesin via Shutterstock. Cambridge-based biotech CN Bio and Altis Biosystems have teamed up to combine in vitro ‘organ-on-a-chip’ systems – Altis’ RepliGut Planar-Jejunum model and CN Bio’s PhysioMimix liver on a chip. CN Bio’s […]
Cognito starts biomarker substudy in Alzheimer’s device trial
Cognito’s non-pharmacological approach involves eliciting gamma-frequency brain activity through non-invasive visual and audio-sensory stimulation via a headset. Image credit: Shutterstock/hessyz. Cognito Therapeutics has enrolled the first patient in a biomarker substudy within its HOPE pivotal trial evaluating sensory stimulation device in Alzheimer’s disease patients. The HOPE study (NCT05637801) is assessing the efficacy of Cognitio’s GammaSense […]
Freenome in artificial intelligence: Theme innovation strategy
Freenome grant share with artificial intelligence as a theme is 0% in Q3 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Markers for the early detection of colon cell proliferative disorders (Patent ID: US20230243830A1) Freenome Inc. has filed a patent for a method […]
ICU Medical in cybersecurity: Theme innovation strategy
ICU Medical grant share with cybersecurity as a theme is 17% in Q3 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Multi-communication path selection and security system for a medical device (Patent ID: US20230253108A1) ICU Medical Inc. has filed a patent for a […]
Topcon in artificial intelligence: Theme innovation strategy
Topcon grant share with artificial intelligence as a theme is 33% in Q3 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Ophthalmic information processing apparatus, ophthalmic apparatus, ophthalmic information processing method, and recording medium (Patent ID: US20230263391A1) The patent filed by Topcon Corp. […]
Shimadzu in artificial intelligence: Theme innovation strategy
Shimadzu grant share with artificial intelligence as a theme is 46% in Q3 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Training support method (Patent ID: US20230267312A1) The patent filed by Shimadzu Corp. describes a training support method for assisting in the training […]
Stryker in artificial intelligence: Theme innovation strategy
Stryker grant share with artificial intelligence as a theme is 13% in Q3 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Implant with sensor redundancy (Patent ID: US20230270566A1) The patent filed by Stryker Corp. describes a joint implant that consists of two implants, […]
ProteinLogic, Stellenbosch to advance ImmiPrint Technology
The technology offers a minimally invasive approach to disease detection and monitoring. Credit: Olga Aniven/Shutterstock.com. Biomarker discovery company ProteinLogic and Stellenbosch University have received a $1.35m grant from the Bill & Melinda Gates Foundation for expediting the development of ImmiPrint Technology for TB. The technology is intended for monitoring treatment responses to TB antimicrobial chemotherapy. […]